The efficacy of anti – toxoplasma drugs in the treatment of schizophrenia , a triple – blind, randomized , placebo-controlled clinical trial
Phase 2
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT201303287373N4
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Inclusion criteria :informed written consent ;diagnosis of schizophrenia according to DSMIV _TR criteria and clinical interview by psychiatrist ;a score of at least 60 in PANSS;age range 15-55
Exclusion criteria: pregnancy ; lactation ;substance abuse; severe physical disease ; contraindication of cotrimoxazole
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PANSS. Timepoint: before intervention and every 2 weeks. Method of measurement: clinical examination.
- Secondary Outcome Measures
Name Time Method Extrapyramidal and skin side effects. Timepoint: befor intervention and every 2 weeks. Method of measurement: clinical examination.